Product Details
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Recombinant human IL-34
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
ELISA Capture - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by ELISA assay. For ELISA capture applications, a concentration range of 2-8 ?g/mL is recommended. To obtain a linear standard curve, serial dilutions of human IL-34 recombinant protein ranging from 5000 to 78 pg/mL are recommended for each ELISA plate. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
ELISA Capture: The purified E0320E7 antibody is useful as the capture antibody in a sandwich ELISA assay, when used in conjunction with the biotinylated E033B8 antibody (Cat. No. 361401) as the detection antibody and recombinant human IL-34 (Cat. No. 577909) as the standard.
Note: For testing human IL-34 in serum, plasma or cell culture supernatant, LEGEND MAX? Human IL-34 ELISA Kit with Pre-coated Plates (Cat. No. 439607 & 439608) are specially developed and recommended.- Product Citations
-
- RRID
- AB_2563032 (BioLegend Cat. No. 361301)
Antigen Details
- Structure
- Secreted glycoprotein, homodimer
- Distribution
- IL-34 mRNA is expressed in many different tissues including: spleen, heart, brain, lung, liver, kidney, thymus, testes, ovary, small intestine, prostate, and colon
- Function
- IL-34 increases monocyte viability, induces macrophage proliferation, and synergizes with other cytokines to generate macrophages and osteoclasts from cultured progenitors. IL-34 promotes the formation of the colony forming unit-macrophage (CFU-M) in human bone marrow culture. IL-34 supports RANKL-induced osteoclastogenesis by promoting the adhesion and proliferation of osteoclast progenitors. Human IL-34 promotes osteoclast differentiation from peripheral blood mononucleated cells. In addition, systematic administration of IL-34 to mouse increases the number of CD11b+ cells and reduces bone mass. IL-1? and TNF-?± induce the expression of interleukin-34 mRNA in osteoblasts. IL-34 is also induced in macrophages infected with equine infectious anemia virus (EIAV).
- Interaction
- Macrophages, monocytes, myeloid cells
- Ligand/Receptor
- CSF-1R
- Biology Area
- Cell Biology, Immunology
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Clanchy FI, et al. 2006. J. Leuko. Biol. 79:757.
2. Lin H, et al. 2008. Science 320:807.
3. Chihara T, et al. 2010. Cell. Death Differ. 17:1917.
4. Wei S, et al. 2010. J. Leuko. Biol. 88:495.
5. Eda H, et al. 2011. Rheumatol. Int. 31:1525. - Gene ID
- 146433 View all products for this Gene ID
- UniProt
- View information about IL-34 on UniProt.org